---
schema_version: "secwatch.filing_event.v1"
accession: "0001104659-23-080188"
form_type: "8-K"
ticker: "VSTM"
cik: "0001526119"
company_name: "Verastem, Inc."
filed_at: "2023-07-12T23:59:59+00:00"
generated_at: "2026-06-13T09:26:34.475024+00:00"
event_type: "leadership"
sentiment: "neutral"
materiality_score: 0.6
calibrated_materiality_score: 0.6
confidence: "high"
source: SEC EDGAR
---

# Verastem Oncology CEO Stuglik retires; President Paterson appointed CEO effective Aug 1

## Summary
- CEO Brian Stuglik retires effective July 31, 2023; receives $421,850 cash bonus.
- President Dan Paterson appointed President and CEO effective August 1, 2023; also joins Board.
- Paterson has 30+ years experience, led acquisition of avutometinib; company moving toward FDA approval in LGSOC.
- Stuglik remains on Board and chairs new Commercialization Committee.
- Committee members Kapur and Tollefson; annual retainers $10k, chair $20k.

## SEC filing metadata
- accession: 0001104659-23-080188
- form_type: 8-K
- ticker: VSTM
- cik: 0001526119
- company_name: Verastem, Inc.
- filed_at: 2023-07-12T23:59:59+00:00
- event_type: leadership
- sentiment: neutral
- materiality_score: 0.6
- calibrated_materiality_score: 0.6
- confidence: high
- sec_items: 5.02, 8.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1526119/000110465923080188/0001104659-23-080188-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1526119/000110465923080188/tm2321108d1_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001104659-23-080188
- JSON: https://secwatch.observer/filing/0001104659-23-080188.json
- Plain text: https://secwatch.observer/filing/0001104659-23-080188.txt

## Key facts
- Executive change
  Brian Stuglik retired as Chief Executive Officer at Verastem, Inc..
  - Action: retired
  - Role: Chief Executive Officer
  source text: On July 7, 2023, Brian Stuglik notified Verastem, Inc. (the “Company)” of his decision to retire as Chief Executive Officer of the Company, effective July 31, 2023
  evidence_url: https://www.sec.gov/Archives/edgar/data/1526119/000110465923080188/0001104659-23-080188-index.htm
- Executive change
  Daniel Paterson was appointed as President and Chief Executive Officer at Verastem, Inc..
  - Action: appointed
  - Role: President and Chief Executive Officer
  source text: Daniel Paterson, 62, the Company’s President and Chief Operating Officer, will be appointed to the position of President and Chief Executive Officer as of the Effective Date.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1526119/000110465923080188/0001104659-23-080188-index.htm
- Executive change
  Daniel Paterson was appointed as Class III director at Verastem, Inc..
  - Action: appointed
  - Role: Class III director
  source text: In connection with his appointment, Mr. Paterson will also be appointed to the Board, to serve as a Class III director.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1526119/000110465923080188/0001104659-23-080188-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.